Back to Search Start Over

Characterization of ANGPT2 mutations associated with primary lymphedema

Authors :
Sawan Kumar Jha
Tuomas Sipilä
Marie Ravoet
Donatella Angelone
Angela D’Elia
Matthieu J. Schlögel
Harri Elamaa
Giovanni Crichiutti
Veerle Labarque
Claudia Luzzatto
Jaakko Kuurne
Miikka Vikkula
Elodie Fastré
Emilia A. Korhonen
Kari Alitalo
Veli-Matti Leppänen
Nicole Revencu
Amihood Singer
Gou Young Koh
Pipsa Saharinen
Pascal Brouillard
CAN-PRO - Translational Cancer Medicine Program
Biosciences
Research Programs Unit
Faculty of Medicine
Helsinki Institute of Life Science HiLIFE
Department of Biochemistry and Developmental Biology
Helsinki In Vivo Animal Imaging Platform (HAIP)
HUSLAB
UCL - SSS/DDUV/GEHU - Génétique
UCL - SSS/IREC/SLUC - Pôle St.-Luc
UCL - (SLuc) Centre de génétique médicale UCL
Source :
Science Translational Medicine, Science translational medicine, Vol. 12, no. 560, p. eaax8013 [1-11] (2020)
Publication Year :
2020
Publisher :
American Association for the Advancement of Science (AAAS), 2020.

Abstract

Lymphedema can occur when tissue fluid cannot enter or leaks from the lymphatic system into surrounding tissues. Some genetic causes of primary lymphedema are known, but these currently explain a minority of cases. Previous studies have shown that dominant-negative mutations in angiopoietin 2 (ANGPT2), which is involved in lymphatic vessel formation and maturation, promote lymphangiogenesis in mice. Leppänen et al. now show that inactivating mutations in angiopoietin 2 associate with primary lymphedema in humans.Primary lymphedema is caused by developmental and functional defects of the lymphatic vascular system that result in accumulation of protein-rich fluid in tissues, resulting in edema. The 28 currently known genes causing primary lymphedema can explain

Details

ISSN :
19466242 and 19466234
Volume :
12
Database :
OpenAIRE
Journal :
Science Translational Medicine
Accession number :
edsair.doi.dedup.....92fd6b2318b488eeeeafe9148c5b475e